CVE-2026-34323: Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Life Sciences InForm. in Oracle Corporation Oracle Life Sciences InForm
Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM Authentication). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Life Sciences InForm. CVSS 3.1 Base Score 6.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L).
AI Analysis
Technical Summary
This vulnerability affects Oracle Life Sciences InForm versions 7.0.1.0 and 7.0.1.1, specifically the IDM Authentication component. It is exploitable remotely over HTTP without authentication, but requires user interaction from a third party. Exploitation can result in unauthorized read and write access to some data and partial denial of service conditions. The CVSS vector (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L) reflects network attack vector, low attack complexity, no privileges required, user interaction required, unchanged scope, and low impacts on confidentiality, integrity, and availability. The vulnerability is listed in Oracle's April 2026 Critical Patch Update advisory, which addresses numerous vulnerabilities across Oracle products, but does not explicitly confirm patch availability or remediation status for this specific issue.
Potential Impact
Successful exploitation can lead to unauthorized read access to some data, unauthorized update, insert, or delete operations on accessible data, and partial denial of service of Oracle Life Sciences InForm. The impact affects confidentiality, integrity, and availability to a limited extent. Exploitation requires user interaction from a person other than the attacker, which may limit the ease of exploitation despite the vulnerability being remotely accessible without authentication.
Mitigation Recommendations
Oracle has included this vulnerability in their April 2026 Critical Patch Update advisory, which contains numerous security patches across multiple products. However, the advisory content provided does not explicitly confirm the availability of a specific patch or official fix for CVE-2026-34323. Therefore, patch status is not yet confirmed—users should consult the Oracle advisory at https://www.oracle.com/security-alerts/cpuapr2026.html for the latest remediation guidance. Oracle strongly recommends applying Critical Patch Updates promptly to mitigate known vulnerabilities. Until a patch is confirmed and applied, organizations should consider limiting network exposure of Oracle Life Sciences InForm and educate users to be cautious of interactions that could trigger exploitation.
CVE-2026-34323: Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Life Sciences InForm. in Oracle Corporation Oracle Life Sciences InForm
Description
Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM Authentication). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Life Sciences InForm. CVSS 3.1 Base Score 6.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L).
AI-Powered Analysis
Machine-generated threat intelligence
Technical Analysis
This vulnerability affects Oracle Life Sciences InForm versions 7.0.1.0 and 7.0.1.1, specifically the IDM Authentication component. It is exploitable remotely over HTTP without authentication, but requires user interaction from a third party. Exploitation can result in unauthorized read and write access to some data and partial denial of service conditions. The CVSS vector (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L) reflects network attack vector, low attack complexity, no privileges required, user interaction required, unchanged scope, and low impacts on confidentiality, integrity, and availability. The vulnerability is listed in Oracle's April 2026 Critical Patch Update advisory, which addresses numerous vulnerabilities across Oracle products, but does not explicitly confirm patch availability or remediation status for this specific issue.
Potential Impact
Successful exploitation can lead to unauthorized read access to some data, unauthorized update, insert, or delete operations on accessible data, and partial denial of service of Oracle Life Sciences InForm. The impact affects confidentiality, integrity, and availability to a limited extent. Exploitation requires user interaction from a person other than the attacker, which may limit the ease of exploitation despite the vulnerability being remotely accessible without authentication.
Mitigation Recommendations
Oracle has included this vulnerability in their April 2026 Critical Patch Update advisory, which contains numerous security patches across multiple products. However, the advisory content provided does not explicitly confirm the availability of a specific patch or official fix for CVE-2026-34323. Therefore, patch status is not yet confirmed—users should consult the Oracle advisory at https://www.oracle.com/security-alerts/cpuapr2026.html for the latest remediation guidance. Oracle strongly recommends applying Critical Patch Updates promptly to mitigate known vulnerabilities. Until a patch is confirmed and applied, organizations should consider limiting network exposure of Oracle Life Sciences InForm and educate users to be cautious of interactions that could trigger exploitation.
Technical Details
- Data Version
- 5.2
- Assigner Short Name
- oracle
- Date Reserved
- 2026-03-26T19:48:45.682Z
- Cvss Version
- 3.1
- State
- PUBLISHED
- Remediation Level
- null
- Vendor Advisory Urls
- [{"url":"https://www.oracle.com/security-alerts/cpuapr2026.html","vendor":"Oracle"}]
Threat ID: 69e7e5ab19fe3cd2cdf9fa10
Added to database: 4/21/2026, 9:01:31 PM
Last enriched: 4/21/2026, 9:32:52 PM
Last updated: 4/22/2026, 7:27:58 AM
Views: 36
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Actions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
External Links
Need more coverage?
Upgrade to Pro Console for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.
Latest Threats
Check if your credentials are on the dark web
Instant breach scanning across billions of leaked records. Free tier available.